Canopy Growth Corp vs Microsoft — how do they compare? Canopy Growth Corp trades at $0.96 (market cap $398.46M), while Microsoft trades at $396.24 (market cap $2.86T). The key difference: Microsoft is far larger — about 7177.6× Canopy Growth Corp's market cap, and Microsoft pays a 0.95% dividend while Canopy Growth Corp pays none. Which is the better fit depends on your goals.
| CGC | MSFT | |
|---|---|---|
Market Cap | $398.46M | $2.86T |
Sector | Health | Technology |
52-Week High | $1.92 | $542.07 |
52-Week Low | $0.86 | $352.83 |
Enterprise Value | $337.90M | $2.84T |
Volume | — | 36,654,621 |
Dividend Yield | — | 0.95% |
Signals from Pluang's Aura AI — not financial advice
Canopy Growth (CGC) trades at $0.96, down 1.15% on the day, with a mixed technical picture showing a bullish overall signal but bearish moving averages. The company reported a net loss of $598.12 million in 2025, with revenue declining to $269 million, though recent quarterly earnings showed one beat and two misses against expectations. Cash flow remains negative, but the balance sheet shows improving debt-to-asset ratios, down to 33.13% in 2025 from 53.61% in 2023.
The outlook is cautious; while cost-cutting and restructuring efforts are underway, profitability remains elusive, and the stock faces risks including potential delisting due to low share price. Analyst sentiment is divided, with 33% recommending buy, 41% hold, and 26% sell. Investors should weigh the potential for a turnaround against significant operational and regulatory challenges in the cannabis sector.
Microsoft (MSFT) trades at $395.63, up 1.19% over the past 24 hours, with a bearish technical signal despite strong fundamentals. The company reported robust earnings beats in recent quarters, including Q1 2026 EPS of $4.27 versus $4.06 expected, driven by revenue growth to $281.72 billion in 2025. Analysts maintain an overwhelmingly bullish consensus with an 80.49% buy rating and a $551.62 price target, though near-term concerns over capital expenditures and AI competition weigh on sentiment.
Outlook remains positive long-term due to Microsoft's leadership in AI and cloud computing, with projected 2026 revenue of $318.3 billion and net income of $125.2 billion. Key risks include elevated valuation multiples, geopolitical tensions, and execution challenges in AI investments. The stock presents a compelling opportunity for growth-oriented investors, supported by solid cash flow generation and a strong balance sheet.
Trailing returns across standard periods
Latest headlines on both assets
Canopy Growth, headquartered in Smiths Falls, Canada, cultivates and sells medicinal and recreational cannabis, and hemp, through a portfolio of brands that include Tweed, Spectrum Therapeutics, and CraftGrow. Although it primarily operates in Canada, Canopy has distribution and production licenses in more than a dozen countries to drive expansion in global medical cannabis and also holds an option to acquire Acreage Holdings upon U.S. federal cannabis legalization.
Read more on CGC →Microsoft Corporation develops, manufactures, licenses, sells, and supports software products. The Company offers operating system software, server application software, business and consumer applications software, software development tools, and Internet and intranet software. Microsoft also develops video game consoles and digital music entertainment devices.
Read more on MSFT →